nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS2—Dexamethasone—atopic dermatitis	0.147	0.263	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—atopic dermatitis	0.035	0.0628	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—atopic dermatitis	0.035	0.0628	CbGbCtD
Doxorubicin—CYP2B6—Diphenhydramine—atopic dermatitis	0.0338	0.0607	CbGbCtD
Doxorubicin—ABCG2—Hydrocortisone—atopic dermatitis	0.0267	0.048	CbGbCtD
Doxorubicin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0239	0.0428	CbGbCtD
Doxorubicin—ABCB1—Tacrolimus—atopic dermatitis	0.0237	0.0425	CbGbCtD
Doxorubicin—ABCC2—Dexamethasone—atopic dermatitis	0.0184	0.033	CbGbCtD
Doxorubicin—ABCB1—Loratadine—atopic dermatitis	0.0173	0.0311	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—atopic dermatitis	0.0166	0.0298	CbGbCtD
Doxorubicin—CYP2D6—Loratadine—atopic dermatitis	0.0163	0.0293	CbGbCtD
Doxorubicin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0163	0.0293	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—atopic dermatitis	0.0158	0.0284	CbGbCtD
Doxorubicin—CYP3A4—Tacrolimus—atopic dermatitis	0.0142	0.0255	CbGbCtD
Doxorubicin—ABCC6—dermis—atopic dermatitis	0.0138	0.264	CbGeAlD
Doxorubicin—CYP2B6—Dexamethasone—atopic dermatitis	0.0117	0.021	CbGbCtD
Doxorubicin—CYP3A4—Loratadine—atopic dermatitis	0.0104	0.0186	CbGbCtD
Doxorubicin—ABCB1—Betamethasone—atopic dermatitis	0.0103	0.0185	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—atopic dermatitis	0.0102	0.0182	CbGbCtD
Doxorubicin—ABCB1—Hydrocortisone—atopic dermatitis	0.00964	0.0173	CbGbCtD
Doxorubicin—ABCB1—Prednisone—atopic dermatitis	0.0096	0.0172	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—atopic dermatitis	0.00949	0.017	CbGbCtD
Doxorubicin—CYP3A4—Triamcinolone—atopic dermatitis	0.0072	0.0129	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—atopic dermatitis	0.00617	0.0111	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—atopic dermatitis	0.00609	0.0109	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—atopic dermatitis	0.00599	0.0108	CbGbCtD
Doxorubicin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00577	0.0104	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—atopic dermatitis	0.00575	0.0103	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—atopic dermatitis	0.00565	0.0101	CbGbCtD
Doxorubicin—CYP3A4—Dexamethasone—atopic dermatitis	0.00359	0.00645	CbGbCtD
Doxorubicin—AKR1A1—skin of body—atopic dermatitis	0.00262	0.0499	CbGeAlD
Doxorubicin—NOS3—neck—atopic dermatitis	0.00233	0.0444	CbGeAlD
Doxorubicin—ABCB8—head—atopic dermatitis	0.0023	0.0438	CbGeAlD
Doxorubicin—CBR3—head—atopic dermatitis	0.00221	0.0421	CbGeAlD
Doxorubicin—NDUFS2—skin of body—atopic dermatitis	0.00197	0.0375	CbGeAlD
Doxorubicin—NDUFS3—skin of body—atopic dermatitis	0.00195	0.0371	CbGeAlD
Doxorubicin—DHCR7—skin of body—atopic dermatitis	0.00185	0.0352	CbGeAlD
Doxorubicin—NQO1—neck—atopic dermatitis	0.00177	0.0337	CbGeAlD
Doxorubicin—AKR1A1—head—atopic dermatitis	0.00171	0.0325	CbGeAlD
Doxorubicin—NDUFS7—head—atopic dermatitis	0.00155	0.0296	CbGeAlD
Doxorubicin—AURKA—head—atopic dermatitis	0.00144	0.0275	CbGeAlD
Doxorubicin—CBR1—skin of body—atopic dermatitis	0.00143	0.0273	CbGeAlD
Doxorubicin—NOS1—head—atopic dermatitis	0.0013	0.0247	CbGeAlD
Doxorubicin—NDUFS2—head—atopic dermatitis	0.00129	0.0245	CbGeAlD
Doxorubicin—NDUFS3—head—atopic dermatitis	0.00127	0.0242	CbGeAlD
Doxorubicin—DHCR7—head—atopic dermatitis	0.00121	0.023	CbGeAlD
Doxorubicin—NDUFS2—Everolimus—Tacrolimus—atopic dermatitis	0.00121	0.161	CbGdCrCtD
Doxorubicin—NDUFS2—Everolimus—Pimecrolimus—atopic dermatitis	0.00121	0.161	CbGdCrCtD
Doxorubicin—ABCC6—head—atopic dermatitis	0.00118	0.0224	CbGeAlD
Doxorubicin—NQO1—skin of body—atopic dermatitis	0.00115	0.0218	CbGeAlD
Doxorubicin—YWHAG—head—atopic dermatitis	0.00111	0.0211	CbGeAlD
Doxorubicin—RALBP1—head—atopic dermatitis	0.001	0.0191	CbGeAlD
Doxorubicin—NOS3—head—atopic dermatitis	0.000985	0.0187	CbGeAlD
Doxorubicin—CBR1—head—atopic dermatitis	0.000935	0.0178	CbGeAlD
Doxorubicin—CYP1B1—skin of body—atopic dermatitis	0.000806	0.0153	CbGeAlD
Doxorubicin—NQO1—head—atopic dermatitis	0.000749	0.0143	CbGeAlD
Doxorubicin—ABCC3—head—atopic dermatitis	0.000672	0.0128	CbGeAlD
Doxorubicin—CYP2B6—skin of body—atopic dermatitis	0.000554	0.0105	CbGeAlD
Doxorubicin—CYP1B1—head—atopic dermatitis	0.000526	0.01	CbGeAlD
Doxorubicin—CYP2B6—head—atopic dermatitis	0.000361	0.00688	CbGeAlD
Doxorubicin—CYP2D6—head—atopic dermatitis	0.000268	0.00511	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Desonide—atopic dermatitis	0.000232	0.0309	CbGdCrCtD
Doxorubicin—AURKA—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000228	0.0304	CbGdCrCtD
Doxorubicin—AURKA—Temsirolimus—Tacrolimus—atopic dermatitis	0.000228	0.0304	CbGdCrCtD
Doxorubicin—AURKA—Sirolimus—Tacrolimus—atopic dermatitis	0.000228	0.0304	CbGdCrCtD
Doxorubicin—AURKA—Sirolimus—Pimecrolimus—atopic dermatitis	0.000228	0.0304	CbGdCrCtD
Doxorubicin—ABCB1—head—atopic dermatitis	0.000193	0.00368	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Desonide—atopic dermatitis	0.000192	0.0256	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Fluocinonide—atopic dermatitis	0.000186	0.0248	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Fluocinolone Acetonide—atopic dermatitis	0.00018	0.0241	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Desonide—atopic dermatitis	0.000176	0.0235	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Fluocinonide—atopic dermatitis	0.000153	0.0205	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Fluocinolone Acetonide—atopic dermatitis	0.000149	0.0199	CbGdCrCtD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000148	0.00198	CbGpPWpGaD
Doxorubicin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atopic dermatitis	0.000144	0.00193	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Mometasone—atopic dermatitis	0.000144	0.0192	CbGdCrCtD
Doxorubicin—NOS3—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000142	0.00191	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FCER2—atopic dermatitis	0.000142	0.0019	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GLB1—atopic dermatitis	0.000142	0.0019	CbGpPWpGaD
Doxorubicin—CBR3—Fluocinolone Acetonide—Fluocinonide—atopic dermatitis	0.000141	0.0188	CbGdCrCtD
Doxorubicin—NOS2—Spinal Cord Injury—IFNG—atopic dermatitis	0.000141	0.00188	CbGpPWpGaD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000141	0.00188	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—IL1B—atopic dermatitis	0.00014	0.00188	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000139	0.00186	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000137	0.00183	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ADSL—atopic dermatitis	0.000136	0.00182	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000136	0.00182	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—PPARA—atopic dermatitis	0.000136	0.00181	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—IL5—atopic dermatitis	0.000136	0.00181	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—SELE—atopic dermatitis	0.000135	0.0018	CbGpPWpGaD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	0.000134	0.00179	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GLB1—atopic dermatitis	0.000132	0.00177	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000132	0.00177	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL22—atopic dermatitis	0.000132	0.00177	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000131	0.00176	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—CXCL8—atopic dermatitis	0.000131	0.00175	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—CASP8—atopic dermatitis	0.00013	0.00174	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KIF3A—atopic dermatitis	0.00013	0.00174	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—MAPK8—atopic dermatitis	0.000129	0.00172	CbGpPWpGaD
Doxorubicin—NOS1—Disease—GLB1—atopic dermatitis	0.000128	0.00172	CbGpPWpGaD
Doxorubicin—NOS2—ATF-2 transcription factor network—IL6—atopic dermatitis	0.000128	0.00171	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ADSL—atopic dermatitis	0.000127	0.00169	CbGpPWpGaD
Doxorubicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000127	0.00169	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—IL1B—atopic dermatitis	0.000126	0.00168	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—IL2—atopic dermatitis	0.000125	0.00167	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	0.000124	0.00166	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—MAPK8—atopic dermatitis	0.000124	0.00165	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000122	0.00163	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000122	0.00163	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TNF—atopic dermatitis	0.000121	0.00162	CbGpPWpGaD
Doxorubicin—CBR3—Triamcinolone—Mometasone—atopic dermatitis	0.000119	0.0159	CbGdCrCtD
Doxorubicin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000119	0.00159	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—IL2—atopic dermatitis	0.000119	0.00159	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL27—atopic dermatitis	0.000118	0.00157	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000117	0.00156	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000115	0.00154	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000115	0.00153	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00011	0.00147	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000109	0.00146	CbGpPWpGaD
Doxorubicin—CBR3—Fluocinolone Acetonide—Mometasone—atopic dermatitis	0.000109	0.0146	CbGdCrCtD
Doxorubicin—NOS3—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	0.000109	0.00146	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	0.000108	0.00144	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL17—atopic dermatitis	0.000106	0.00141	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SELE—atopic dermatitis	0.000105	0.0014	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000103	0.00138	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.000102	0.00137	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IL5—atopic dermatitis	0.000102	0.00137	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000102	0.00136	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—IL6—atopic dermatitis	0.000101	0.00135	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.0001	0.00134	CbGpPWpGaD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	9.87e-05	0.00132	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—TNF—atopic dermatitis	9.85e-05	0.00132	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	9.82e-05	0.00131	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—IL6—atopic dermatitis	9.76e-05	0.00131	CbGpPWpGaD
Doxorubicin—NOS2—Disease—GLB1—atopic dermatitis	9.67e-05	0.00129	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.63e-05	0.00129	CbGpPWpGaD
Doxorubicin—CBR3—Betamethasone—Desonide—atopic dermatitis	9.47e-05	0.0126	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Desonide—atopic dermatitis	9.47e-05	0.0126	CbGdCrCtD
Doxorubicin—RALBP1—Signaling Pathways—KIF3A—atopic dermatitis	9.41e-05	0.00126	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—PPARA—atopic dermatitis	9.27e-05	0.00124	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TNF—atopic dermatitis	9.12e-05	0.00122	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Hydrocortisone—atopic dermatitis	9.11e-05	0.0122	CbGdCrCtD
Doxorubicin—YWHAG—Apoptosis—MAPK8—atopic dermatitis	9.06e-05	0.00121	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GLB1—atopic dermatitis	8.89e-05	0.00119	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	8.87e-05	0.00119	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	8.87e-05	0.00119	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.75e-05	0.00117	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.6e-05	0.00115	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—atopic dermatitis	8.6e-05	0.0115	CbGdCrCtD
Doxorubicin—NOS1—Disease—SLC11A1—atopic dermatitis	8.59e-05	0.00115	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.54e-05	0.00114	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL11—atopic dermatitis	8.51e-05	0.00114	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CMA1—atopic dermatitis	8.51e-05	0.00114	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—atopic dermatitis	8.46e-05	0.0113	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—atopic dermatitis	8.46e-05	0.0113	CbGdCrCtD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.32e-05	0.00111	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—atopic dermatitis	8.27e-05	0.011	CbGdCrCtD
Doxorubicin—RALBP1—Signaling Pathways—STAT6—atopic dermatitis	8e-05	0.00107	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—IL6—atopic dermatitis	7.95e-05	0.00106	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL5—atopic dermatitis	7.94e-05	0.00106	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FCER2—atopic dermatitis	7.87e-05	0.00105	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Prednisone—atopic dermatitis	7.85e-05	0.0105	CbGdCrCtD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	7.84e-05	0.00105	CbGpPWpGaD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	7.84e-05	0.00105	CbGpPWpGaD
Doxorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	7.8e-05	0.00104	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GLB1—atopic dermatitis	7.71e-05	0.00103	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.71e-05	0.00103	CbGpPWpGaD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—atopic dermatitis	7.66e-05	0.0102	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Fluocinonide—atopic dermatitis	7.58e-05	0.0101	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Fluocinonide—atopic dermatitis	7.58e-05	0.0101	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Hydrocortisone—atopic dermatitis	7.53e-05	0.01	CbGdCrCtD
Doxorubicin—NOS2—Circadian rythm related genes—MAPK8—atopic dermatitis	7.53e-05	0.00101	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GLB1—atopic dermatitis	7.51e-05	0.001	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GLB1—atopic dermatitis	7.44e-05	0.000996	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	7.43e-05	0.000995	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ADSL—atopic dermatitis	7.39e-05	0.000989	CbGpPWpGaD
Doxorubicin—CBR3—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	7.37e-05	0.00983	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	7.37e-05	0.00983	CbGdCrCtD
Doxorubicin—NOS2—Spinal Cord Injury—IL6—atopic dermatitis	7.36e-05	0.000984	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL22—atopic dermatitis	7.32e-05	0.000979	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	7.23e-05	0.000968	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TNF—atopic dermatitis	7.17e-05	0.000959	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ADSL—atopic dermatitis	7.13e-05	0.000954	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—atopic dermatitis	7.13e-05	0.000954	CbGpPWpGaD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—atopic dermatitis	7.1e-05	0.00948	CbGdCrCtD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.1e-05	0.00095	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.99e-05	0.000936	CbGpPWpGaD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—atopic dermatitis	6.99e-05	0.00933	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—atopic dermatitis	6.99e-05	0.00933	CbGdCrCtD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	6.94e-05	0.000929	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCR3—atopic dermatitis	6.94e-05	0.000928	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GLB1—atopic dermatitis	6.92e-05	0.000926	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FCER2—atopic dermatitis	6.65e-05	0.00089	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ADSL—atopic dermatitis	6.63e-05	0.000887	CbGpPWpGaD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—atopic dermatitis	6.53e-05	0.00871	CbGdCrCtD
Doxorubicin—AKR1C3—Signaling Pathways—CCL27—atopic dermatitis	6.52e-05	0.000873	CbGpPWpGaD
Doxorubicin—CBR3—Triamcinolone—Prednisone—atopic dermatitis	6.48e-05	0.00865	CbGdCrCtD
Doxorubicin—NOS2—Disease—SLC11A1—atopic dermatitis	6.48e-05	0.000867	CbGpPWpGaD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—atopic dermatitis	6.43e-05	0.00858	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—atopic dermatitis	6.43e-05	0.00858	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—atopic dermatitis	6.33e-05	0.00845	CbGdCrCtD
Doxorubicin—NOS3—Metabolism—GLB1—atopic dermatitis	6.29e-05	0.000841	CbGpPWpGaD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—atopic dermatitis	6.28e-05	0.00838	CbGdCrCtD
Doxorubicin—Oedema—Hydrocortisone—atopic dermatitis	6.23e-05	0.000202	CcSEcCtD
Doxorubicin—Convulsion—Triamcinolone—atopic dermatitis	6.22e-05	0.000202	CcSEcCtD
Doxorubicin—Tachycardia—Prednisolone—atopic dermatitis	6.22e-05	0.000202	CcSEcCtD
Doxorubicin—Convulsion—Methylprednisolone—atopic dermatitis	6.21e-05	0.000202	CcSEcCtD
Doxorubicin—Hypertension—Triamcinolone—atopic dermatitis	6.2e-05	0.000201	CcSEcCtD
Doxorubicin—Hypertension—Methylprednisolone—atopic dermatitis	6.19e-05	0.000201	CcSEcCtD
Doxorubicin—Infection—Hydrocortisone—atopic dermatitis	6.19e-05	0.000201	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—TAC1—atopic dermatitis	6.18e-05	0.000827	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NPS—atopic dermatitis	6.18e-05	0.000827	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL22—atopic dermatitis	6.18e-05	0.000827	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	6.18e-05	0.000827	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Prednisolone—atopic dermatitis	6.16e-05	0.0002	CcSEcCtD
Doxorubicin—Shock—Hydrocortisone—atopic dermatitis	6.13e-05	0.000199	CcSEcCtD
Doxorubicin—Myalgia—Triamcinolone—atopic dermatitis	6.12e-05	0.000198	CcSEcCtD
Doxorubicin—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.11e-05	0.000198	CcSEcCtD
Doxorubicin—Myalgia—Methylprednisolone—atopic dermatitis	6.1e-05	0.000198	CcSEcCtD
Doxorubicin—Arthralgia—Methylprednisolone—atopic dermatitis	6.1e-05	0.000198	CcSEcCtD
Doxorubicin—Eye disorder—Prednisone—atopic dermatitis	6.09e-05	0.000198	CcSEcCtD
Doxorubicin—Anxiety—Methylprednisolone—atopic dermatitis	6.08e-05	0.000197	CcSEcCtD
Doxorubicin—Tachycardia—Hydrocortisone—atopic dermatitis	6.08e-05	0.000197	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—CXCR3—atopic dermatitis	6.06e-05	0.000811	CbGpPWpGaD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	6.06e-05	0.000197	CcSEcCtD
Doxorubicin—Flushing—Prednisone—atopic dermatitis	6.05e-05	0.000196	CcSEcCtD
Doxorubicin—Skin disorder—Hydrocortisone—atopic dermatitis	6.05e-05	0.000196	CcSEcCtD
Doxorubicin—Ill-defined disorder—Dexamethasone—atopic dermatitis	6.05e-05	0.000196	CcSEcCtD
Doxorubicin—Ill-defined disorder—Betamethasone—atopic dermatitis	6.05e-05	0.000196	CcSEcCtD
Doxorubicin—Discomfort—Triamcinolone—atopic dermatitis	6.04e-05	0.000196	CcSEcCtD
Doxorubicin—Discomfort—Methylprednisolone—atopic dermatitis	6.03e-05	0.000196	CcSEcCtD
Doxorubicin—NOS3—Metabolism—ADSL—atopic dermatitis	6.03e-05	0.000806	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	6.02e-05	0.000195	CcSEcCtD
Doxorubicin—Dry mouth—Triamcinolone—atopic dermatitis	5.98e-05	0.000194	CcSEcCtD
Doxorubicin—AKR1C3—Disease—SLC11A1—atopic dermatitis	5.95e-05	0.000796	CbGpPWpGaD
Doxorubicin—Anorexia—Hydrocortisone—atopic dermatitis	5.93e-05	0.000193	CcSEcCtD
Doxorubicin—Nausea—Tacrolimus—atopic dermatitis	5.93e-05	0.000192	CcSEcCtD
Doxorubicin—Angiopathy—Prednisone—atopic dermatitis	5.92e-05	0.000192	CcSEcCtD
Doxorubicin—Confusional state—Methylprednisolone—atopic dermatitis	5.9e-05	0.000191	CcSEcCtD
Doxorubicin—Immune system disorder—Prednisone—atopic dermatitis	5.89e-05	0.000191	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Mometasone—atopic dermatitis	5.88e-05	0.00785	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Mometasone—atopic dermatitis	5.88e-05	0.00785	CbGdCrCtD
Doxorubicin—Malaise—Dexamethasone—atopic dermatitis	5.88e-05	0.000191	CcSEcCtD
Doxorubicin—Malaise—Betamethasone—atopic dermatitis	5.88e-05	0.000191	CcSEcCtD
Doxorubicin—Anaphylactic shock—Triamcinolone—atopic dermatitis	5.86e-05	0.00019	CcSEcCtD
Doxorubicin—Oedema—Triamcinolone—atopic dermatitis	5.86e-05	0.00019	CcSEcCtD
Doxorubicin—Vertigo—Betamethasone—atopic dermatitis	5.86e-05	0.00019	CcSEcCtD
Doxorubicin—Vertigo—Dexamethasone—atopic dermatitis	5.86e-05	0.00019	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—CCL17—atopic dermatitis	5.85e-05	0.000783	CbGpPWpGaD
Doxorubicin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	5.85e-05	0.00019	CcSEcCtD
Doxorubicin—Syncope—Dexamethasone—atopic dermatitis	5.85e-05	0.00019	CcSEcCtD
Doxorubicin—Syncope—Betamethasone—atopic dermatitis	5.85e-05	0.00019	CcSEcCtD
Doxorubicin—NOS3—Signaling by VEGF—IL6—atopic dermatitis	5.83e-05	0.00078	CbGpPWpGaD
Doxorubicin—Arrhythmia—Prednisone—atopic dermatitis	5.82e-05	0.000189	CcSEcCtD
Doxorubicin—Infection—Triamcinolone—atopic dermatitis	5.82e-05	0.000189	CcSEcCtD
Doxorubicin—Hypotension—Hydrocortisone—atopic dermatitis	5.82e-05	0.000189	CcSEcCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—atopic dermatitis	5.82e-05	0.00776	CbGdCrCtD
Doxorubicin—Infection—Methylprednisolone—atopic dermatitis	5.81e-05	0.000189	CcSEcCtD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	5.78e-05	0.000774	CbGpPWpGaD
Doxorubicin—Shock—Triamcinolone—atopic dermatitis	5.77e-05	0.000187	CcSEcCtD
Doxorubicin—Insomnia—Prednisolone—atopic dermatitis	5.77e-05	0.000187	CcSEcCtD
Doxorubicin—Alopecia—Prednisone—atopic dermatitis	5.76e-05	0.000187	CcSEcCtD
Doxorubicin—Shock—Methylprednisolone—atopic dermatitis	5.75e-05	0.000187	CcSEcCtD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—IL6—atopic dermatitis	5.75e-05	0.00077	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PPARA—atopic dermatitis	5.75e-05	0.000769	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PPARA—atopic dermatitis	5.75e-05	0.000769	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL5—atopic dermatitis	5.75e-05	0.000769	CbGpPWpGaD
Doxorubicin—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.74e-05	0.000186	CcSEcCtD
Doxorubicin—Loss of consciousness—Betamethasone—atopic dermatitis	5.73e-05	0.000186	CcSEcCtD
Doxorubicin—Loss of consciousness—Dexamethasone—atopic dermatitis	5.73e-05	0.000186	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisolone—atopic dermatitis	5.72e-05	0.000186	CcSEcCtD
Doxorubicin—Tachycardia—Triamcinolone—atopic dermatitis	5.72e-05	0.000186	CcSEcCtD
Doxorubicin—Mental disorder—Prednisone—atopic dermatitis	5.71e-05	0.000185	CcSEcCtD
Doxorubicin—Tachycardia—Methylprednisolone—atopic dermatitis	5.71e-05	0.000185	CcSEcCtD
Doxorubicin—Skin disorder—Methylprednisolone—atopic dermatitis	5.68e-05	0.000184	CcSEcCtD
Doxorubicin—Erythema—Prednisone—atopic dermatitis	5.68e-05	0.000184	CcSEcCtD
Doxorubicin—Malnutrition—Prednisone—atopic dermatitis	5.68e-05	0.000184	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.67e-05	0.000184	CcSEcCtD
Doxorubicin—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.67e-05	0.000184	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.65e-05	0.000184	CcSEcCtD
Doxorubicin—Convulsion—Dexamethasone—atopic dermatitis	5.65e-05	0.000183	CcSEcCtD
Doxorubicin—Convulsion—Betamethasone—atopic dermatitis	5.65e-05	0.000183	CcSEcCtD
Doxorubicin—Insomnia—Hydrocortisone—atopic dermatitis	5.63e-05	0.000183	CcSEcCtD
Doxorubicin—Hypertension—Dexamethasone—atopic dermatitis	5.63e-05	0.000183	CcSEcCtD
Doxorubicin—Hypertension—Betamethasone—atopic dermatitis	5.63e-05	0.000183	CcSEcCtD
Doxorubicin—Paraesthesia—Hydrocortisone—atopic dermatitis	5.59e-05	0.000181	CcSEcCtD
Doxorubicin—Myalgia—Betamethasone—atopic dermatitis	5.55e-05	0.00018	CcSEcCtD
Doxorubicin—Myalgia—Dexamethasone—atopic dermatitis	5.55e-05	0.00018	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.55e-05	0.000742	CbGpPWpGaD
Doxorubicin—Anxiety—Betamethasone—atopic dermatitis	5.53e-05	0.000179	CcSEcCtD
Doxorubicin—Anxiety—Dexamethasone—atopic dermatitis	5.53e-05	0.000179	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—CCL27—atopic dermatitis	5.51e-05	0.000737	CbGpPWpGaD
Doxorubicin—Discomfort—Betamethasone—atopic dermatitis	5.48e-05	0.000178	CcSEcCtD
Doxorubicin—Discomfort—Dexamethasone—atopic dermatitis	5.48e-05	0.000178	CcSEcCtD
Doxorubicin—Dyspepsia—Hydrocortisone—atopic dermatitis	5.48e-05	0.000178	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.48e-05	0.000733	CbGpPWpGaD
Doxorubicin—Hypotension—Methylprednisolone—atopic dermatitis	5.47e-05	0.000177	CcSEcCtD
Doxorubicin—Pain—Prednisolone—atopic dermatitis	5.45e-05	0.000177	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.42e-05	0.000725	CbGpPWpGaD
Doxorubicin—Decreased appetite—Hydrocortisone—atopic dermatitis	5.41e-05	0.000176	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—PPARA—atopic dermatitis	5.41e-05	0.000723	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.38e-05	0.000174	CcSEcCtD
Doxorubicin—Fatigue—Hydrocortisone—atopic dermatitis	5.37e-05	0.000174	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.36e-05	0.000717	CbGpPWpGaD
Doxorubicin—Vision blurred—Prednisone—atopic dermatitis	5.35e-05	0.000174	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.34e-05	0.000173	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.33e-05	0.000173	CcSEcCtD
Doxorubicin—Pain—Hydrocortisone—atopic dermatitis	5.32e-05	0.000173	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—atopic dermatitis	5.32e-05	0.000173	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—atopic dermatitis	5.32e-05	0.000173	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—atopic dermatitis	5.32e-05	0.000173	CcSEcCtD
Doxorubicin—Oedema—Betamethasone—atopic dermatitis	5.32e-05	0.000173	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—atopic dermatitis	5.3e-05	0.000172	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—atopic dermatitis	5.29e-05	0.000172	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—atopic dermatitis	5.28e-05	0.000172	CcSEcCtD
Doxorubicin—Infection—Betamethasone—atopic dermatitis	5.28e-05	0.000172	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—atopic dermatitis	5.27e-05	0.000171	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—atopic dermatitis	5.26e-05	0.000171	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—atopic dermatitis	5.25e-05	0.000171	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—atopic dermatitis	5.25e-05	0.00017	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—atopic dermatitis	5.25e-05	0.00017	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—atopic dermatitis	5.23e-05	0.00017	CcSEcCtD
Doxorubicin—Shock—Betamethasone—atopic dermatitis	5.23e-05	0.00017	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—atopic dermatitis	5.23e-05	0.00017	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—atopic dermatitis	5.22e-05	0.000169	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—atopic dermatitis	5.22e-05	0.000169	CcSEcCtD
Doxorubicin—Agitation—Prednisone—atopic dermatitis	5.22e-05	0.000169	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—KIF3A—atopic dermatitis	5.21e-05	0.000698	CbGpPWpGaD
Doxorubicin—Thrombocytopenia—Dexamethasone—atopic dermatitis	5.21e-05	0.000169	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—atopic dermatitis	5.21e-05	0.000169	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—atopic dermatitis	5.19e-05	0.000168	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—atopic dermatitis	5.19e-05	0.000168	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—IL2—atopic dermatitis	5.18e-05	0.000693	CbGpPWpGaD
Doxorubicin—Dyspepsia—Triamcinolone—atopic dermatitis	5.16e-05	0.000167	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—atopic dermatitis	5.15e-05	0.000167	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—MAPK8—atopic dermatitis	5.14e-05	0.000688	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Betamethasone—atopic dermatitis	5.14e-05	0.000167	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.14e-05	0.000167	CcSEcCtD
Doxorubicin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.14e-05	0.000688	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.13e-05	0.000167	CcSEcCtD
Doxorubicin—Malaise—Prednisone—atopic dermatitis	5.12e-05	0.000166	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—GLB1—atopic dermatitis	5.1e-05	0.000682	CbGpPWpGaD
Doxorubicin—Vertigo—Prednisone—atopic dermatitis	5.1e-05	0.000166	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.09e-05	0.000165	CcSEcCtD
Doxorubicin—Syncope—Prednisone—atopic dermatitis	5.09e-05	0.000165	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—atopic dermatitis	5.07e-05	0.000165	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—atopic dermatitis	5.07e-05	0.000165	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—atopic dermatitis	5.06e-05	0.000164	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—atopic dermatitis	5.05e-05	0.000164	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—atopic dermatitis	5.04e-05	0.000164	CcSEcCtD
Doxorubicin—NOS3—Disease—SLC11A1—atopic dermatitis	5.03e-05	0.000673	CbGpPWpGaD
Doxorubicin—Pain—Triamcinolone—atopic dermatitis	5.01e-05	0.000163	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—atopic dermatitis	4.99e-05	0.000162	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—atopic dermatitis	4.97e-05	0.000161	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—atopic dermatitis	4.97e-05	0.000161	CcSEcCtD
Doxorubicin—Urticaria—Hydrocortisone—atopic dermatitis	4.95e-05	0.000161	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—CCL17—atopic dermatitis	4.94e-05	0.000661	CbGpPWpGaD
Doxorubicin—Abdominal pain—Hydrocortisone—atopic dermatitis	4.92e-05	0.00016	CcSEcCtD
Doxorubicin—Body temperature increased—Hydrocortisone—atopic dermatitis	4.92e-05	0.00016	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—atopic dermatitis	4.92e-05	0.00016	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—CXCL10—atopic dermatitis	4.9e-05	0.000656	CbGpPWpGaD
Doxorubicin—Hypertension—Prednisone—atopic dermatitis	4.9e-05	0.000159	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—ADSL—atopic dermatitis	4.89e-05	0.000654	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GLB1—atopic dermatitis	4.89e-05	0.000654	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	4.85e-05	0.000157	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	4.85e-05	0.000157	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—atopic dermatitis	4.83e-05	0.000157	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—atopic dermatitis	4.83e-05	0.000157	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—atopic dermatitis	4.83e-05	0.000157	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.82e-05	0.000645	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.82e-05	0.000156	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—atopic dermatitis	4.82e-05	0.000156	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—atopic dermatitis	4.81e-05	0.000156	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—atopic dermatitis	4.81e-05	0.000156	CcSEcCtD
Doxorubicin—NOS2—Circadian rythm related genes—IL6—atopic dermatitis	4.81e-05	0.000643	CbGpPWpGaD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	4.8e-05	0.000156	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.78e-05	0.000155	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—atopic dermatitis	4.78e-05	0.000155	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—atopic dermatitis	4.78e-05	0.000155	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—atopic dermatitis	4.77e-05	0.000155	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—CMA1—atopic dermatitis	4.72e-05	0.000631	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL11—atopic dermatitis	4.72e-05	0.000631	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Prednisolone—atopic dermatitis	4.7e-05	0.000152	CcSEcCtD
Doxorubicin—ABCC3—Metabolism—ADSL—atopic dermatitis	4.69e-05	0.000627	CbGpPWpGaD
Doxorubicin—Dyspepsia—Betamethasone—atopic dermatitis	4.68e-05	0.000152	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—atopic dermatitis	4.68e-05	0.000152	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—atopic dermatitis	4.66e-05	0.000151	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—atopic dermatitis	4.65e-05	0.000151	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—atopic dermatitis	4.63e-05	0.00015	CcSEcCtD
Doxorubicin—Oedema—Prednisone—atopic dermatitis	4.63e-05	0.00015	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—atopic dermatitis	4.63e-05	0.00015	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—atopic dermatitis	4.62e-05	0.00015	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—atopic dermatitis	4.62e-05	0.00015	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—atopic dermatitis	4.62e-05	0.00015	CcSEcCtD
Doxorubicin—Infection—Prednisone—atopic dermatitis	4.6e-05	0.000149	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—PPARA—atopic dermatitis	4.6e-05	0.000615	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	4.59e-05	0.000615	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.59e-05	0.000149	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.59e-05	0.000149	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.59e-05	0.000149	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—atopic dermatitis	4.59e-05	0.000149	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—atopic dermatitis	4.59e-05	0.000149	CcSEcCtD
Doxorubicin—ABCC1—Disease—GLB1—atopic dermatitis	4.57e-05	0.000612	CbGpPWpGaD
Doxorubicin—Shock—Prednisone—atopic dermatitis	4.56e-05	0.000148	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—atopic dermatitis	4.55e-05	0.000148	CcSEcCtD
Doxorubicin—Pain—Betamethasone—atopic dermatitis	4.55e-05	0.000148	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—atopic dermatitis	4.54e-05	0.000147	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—atopic dermatitis	4.52e-05	0.000147	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—atopic dermatitis	4.5e-05	0.000146	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—atopic dermatitis	4.48e-05	0.000145	CcSEcCtD
Doxorubicin—Asthenia—Hydrocortisone—atopic dermatitis	4.47e-05	0.000145	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—STAT6—atopic dermatitis	4.43e-05	0.000593	CbGpPWpGaD
Doxorubicin—Anorexia—Prednisone—atopic dermatitis	4.42e-05	0.000143	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—KIF3A—atopic dermatitis	4.41e-05	0.000589	CbGpPWpGaD
Doxorubicin—Pruritus—Hydrocortisone—atopic dermatitis	4.4e-05	0.000143	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—atopic dermatitis	4.38e-05	0.000142	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—atopic dermatitis	4.38e-05	0.000142	CcSEcCtD
Doxorubicin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	4.37e-05	0.000585	CbGpPWpGaD
Doxorubicin—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.35e-05	0.000141	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.35e-05	0.000141	CcSEcCtD
Doxorubicin—NOS1—Disease—CCR5—atopic dermatitis	4.34e-05	0.000581	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Triamcinolone—atopic dermatitis	4.32e-05	0.00014	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.31e-05	0.00014	CcSEcCtD
Doxorubicin—CBR1—Metabolism—PPARA—atopic dermatitis	4.29e-05	0.000574	CbGpPWpGaD
Doxorubicin—Diarrhoea—Hydrocortisone—atopic dermatitis	4.26e-05	0.000138	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.24e-05	0.000567	CbGpPWpGaD
Doxorubicin—Urticaria—Dexamethasone—atopic dermatitis	4.23e-05	0.000137	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—atopic dermatitis	4.23e-05	0.000137	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.22e-05	0.000137	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—CCL5—atopic dermatitis	4.22e-05	0.000564	CbGpPWpGaD
Doxorubicin—Dizziness—Prednisolone—atopic dermatitis	4.22e-05	0.000137	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—atopic dermatitis	4.21e-05	0.000137	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—atopic dermatitis	4.21e-05	0.000136	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—atopic dermatitis	4.21e-05	0.000136	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—atopic dermatitis	4.21e-05	0.000136	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—atopic dermatitis	4.21e-05	0.000136	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—atopic dermatitis	4.2e-05	0.000136	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—atopic dermatitis	4.19e-05	0.000136	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—atopic dermatitis	4.16e-05	0.000135	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—atopic dermatitis	4.15e-05	0.000135	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—atopic dermatitis	4.14e-05	0.000134	CcSEcCtD
Doxorubicin—Dizziness—Hydrocortisone—atopic dermatitis	4.12e-05	0.000134	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—atopic dermatitis	4.08e-05	0.000132	CcSEcCtD
Doxorubicin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	4.06e-05	0.000544	CbGpPWpGaD
Doxorubicin—Decreased appetite—Prednisone—atopic dermatitis	4.03e-05	0.000131	CcSEcCtD
Doxorubicin—Rash—Prednisolone—atopic dermatitis	4.02e-05	0.00013	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—atopic dermatitis	4.02e-05	0.00013	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—atopic dermatitis	4e-05	0.00013	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—atopic dermatitis	3.99e-05	0.00013	CcSEcCtD
Doxorubicin—Headache—Prednisolone—atopic dermatitis	3.99e-05	0.00013	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—CCL11—atopic dermatitis	3.98e-05	0.000533	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CMA1—atopic dermatitis	3.98e-05	0.000533	CbGpPWpGaD
Doxorubicin—Constipation—Prednisone—atopic dermatitis	3.96e-05	0.000129	CcSEcCtD
Doxorubicin—Vomiting—Hydrocortisone—atopic dermatitis	3.96e-05	0.000128	CcSEcCtD
Doxorubicin—Rash—Hydrocortisone—atopic dermatitis	3.93e-05	0.000127	CcSEcCtD
Doxorubicin—Dermatitis—Hydrocortisone—atopic dermatitis	3.92e-05	0.000127	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—NGF—atopic dermatitis	3.91e-05	0.000523	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IL2—atopic dermatitis	3.91e-05	0.000523	CbGpPWpGaD
Doxorubicin—Headache—Hydrocortisone—atopic dermatitis	3.9e-05	0.000127	CcSEcCtD
Doxorubicin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	3.9e-05	0.000522	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	3.88e-05	0.00052	CbGpPWpGaD
Doxorubicin—Dizziness—Triamcinolone—atopic dermatitis	3.88e-05	0.000126	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—atopic dermatitis	3.87e-05	0.000126	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—CCR3—atopic dermatitis	3.84e-05	0.000514	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.84e-05	0.000514	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GLB1—atopic dermatitis	3.83e-05	0.000513	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Prednisone—atopic dermatitis	3.82e-05	0.000124	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—atopic dermatitis	3.82e-05	0.000124	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—atopic dermatitis	3.82e-05	0.000124	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—CCR5—atopic dermatitis	3.8e-05	0.000509	CbGpPWpGaD
Doxorubicin—Gastrointestinal pain—Prednisone—atopic dermatitis	3.79e-05	0.000123	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—atopic dermatitis	3.79e-05	0.000123	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—atopic dermatitis	3.76e-05	0.000122	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—atopic dermatitis	3.76e-05	0.000122	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—STAT6—atopic dermatitis	3.75e-05	0.000501	CbGpPWpGaD
Doxorubicin—Vomiting—Triamcinolone—atopic dermatitis	3.73e-05	0.000121	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Hydrocortisone—atopic dermatitis	3.72e-05	0.00497	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Hydrocortisone—atopic dermatitis	3.72e-05	0.00497	CbGdCrCtD
Doxorubicin—Vomiting—Methylprednisolone—atopic dermatitis	3.72e-05	0.000121	CcSEcCtD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.72e-05	0.000497	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GLB1—atopic dermatitis	3.71e-05	0.000496	CbGpPWpGaD
Doxorubicin—Nausea—Hydrocortisone—atopic dermatitis	3.7e-05	0.00012	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—atopic dermatitis	3.7e-05	0.00012	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—atopic dermatitis	3.69e-05	0.00012	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—atopic dermatitis	3.69e-05	0.00012	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—atopic dermatitis	3.68e-05	0.00012	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—atopic dermatitis	3.68e-05	0.000119	CcSEcCtD
Doxorubicin—ABCC1—Metabolism—ADSL—atopic dermatitis	3.67e-05	0.000491	CbGpPWpGaD
Doxorubicin—Headache—Triamcinolone—atopic dermatitis	3.67e-05	0.000119	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—atopic dermatitis	3.66e-05	0.000119	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—atopic dermatitis	3.66e-05	0.000119	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—atopic dermatitis	3.66e-05	0.000119	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—atopic dermatitis	3.64e-05	0.000118	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—atopic dermatitis	3.64e-05	0.000118	CcSEcCtD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.56e-05	0.000477	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ADSL—atopic dermatitis	3.55e-05	0.000475	CbGpPWpGaD
Doxorubicin—Dizziness—Betamethasone—atopic dermatitis	3.52e-05	0.000114	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—atopic dermatitis	3.52e-05	0.000114	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—atopic dermatitis	3.51e-05	0.00469	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—atopic dermatitis	3.51e-05	0.00469	CbGdCrCtD
Doxorubicin—Nausea—Triamcinolone—atopic dermatitis	3.48e-05	0.000113	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—atopic dermatitis	3.47e-05	0.000113	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—atopic dermatitis	3.46e-05	0.00461	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—atopic dermatitis	3.46e-05	0.00461	CbGdCrCtD
Doxorubicin—AKR1C3—Signaling Pathways—NPS—atopic dermatitis	3.43e-05	0.000458	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TAC1—atopic dermatitis	3.43e-05	0.000458	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Prednisone—atopic dermatitis	3.41e-05	0.000111	CcSEcCtD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.39e-05	0.000453	CbGpPWpGaD
Doxorubicin—Vomiting—Dexamethasone—atopic dermatitis	3.38e-05	0.00011	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—atopic dermatitis	3.38e-05	0.00011	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—atopic dermatitis	3.38e-05	0.00451	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—atopic dermatitis	3.38e-05	0.00451	CbGdCrCtD
Doxorubicin—ABCG2—Metabolism—GLB1—atopic dermatitis	3.37e-05	0.000451	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCR3—atopic dermatitis	3.36e-05	0.00045	CbGpPWpGaD
Doxorubicin—Rash—Betamethasone—atopic dermatitis	3.35e-05	0.000109	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—atopic dermatitis	3.35e-05	0.000109	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—atopic dermatitis	3.35e-05	0.000109	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—atopic dermatitis	3.35e-05	0.000109	CcSEcCtD
Doxorubicin—Headache—Betamethasone—atopic dermatitis	3.33e-05	0.000108	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—atopic dermatitis	3.33e-05	0.000108	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—atopic dermatitis	3.32e-05	0.000108	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—IL6—atopic dermatitis	3.29e-05	0.000439	CbGpPWpGaD
Doxorubicin—Pruritus—Prednisone—atopic dermatitis	3.28e-05	0.000106	CcSEcCtD
Doxorubicin—NOS2—Disease—CCR5—atopic dermatitis	3.27e-05	0.000438	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR3—atopic dermatitis	3.25e-05	0.000435	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADSL—atopic dermatitis	3.23e-05	0.000432	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NFKBIA—atopic dermatitis	3.22e-05	0.000431	CbGpPWpGaD
Doxorubicin—CBR3—Dexamethasone—Prednisone—atopic dermatitis	3.2e-05	0.00428	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—atopic dermatitis	3.2e-05	0.00428	CbGdCrCtD
Doxorubicin—AKR1C3—Signaling Pathways—IL5—atopic dermatitis	3.19e-05	0.000426	CbGpPWpGaD
Doxorubicin—Diarrhoea—Prednisone—atopic dermatitis	3.17e-05	0.000103	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—atopic dermatitis	3.16e-05	0.000103	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—atopic dermatitis	3.16e-05	0.000103	CcSEcCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—atopic dermatitis	3.13e-05	0.00417	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—atopic dermatitis	3.13e-05	0.00417	CbGdCrCtD
Doxorubicin—ABCC1—Disease—SLC11A1—atopic dermatitis	3.06e-05	0.00041	CbGpPWpGaD
Doxorubicin—Dizziness—Prednisone—atopic dermatitis	3.06e-05	9.94e-05	CcSEcCtD
Doxorubicin—NOS3—Hemostasis—IL2—atopic dermatitis	3.03e-05	0.000406	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CCR5—atopic dermatitis	3.01e-05	0.000402	CbGpPWpGaD
Doxorubicin—Vomiting—Prednisone—atopic dermatitis	2.95e-05	9.56e-05	CcSEcCtD
Doxorubicin—Rash—Prednisone—atopic dermatitis	2.92e-05	9.48e-05	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—atopic dermatitis	2.92e-05	9.47e-05	CcSEcCtD
Doxorubicin—Headache—Prednisone—atopic dermatitis	2.9e-05	9.42e-05	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—NPS—atopic dermatitis	2.9e-05	0.000387	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TAC1—atopic dermatitis	2.9e-05	0.000387	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCR3—atopic dermatitis	2.84e-05	0.00038	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.83e-05	0.000379	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.81e-05	0.000376	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.79e-05	0.000374	CbGpPWpGaD
Doxorubicin—Nausea—Prednisone—atopic dermatitis	2.75e-05	8.93e-05	CcSEcCtD
Doxorubicin—NOS1—Disease—CD4—atopic dermatitis	2.72e-05	0.000365	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL10—atopic dermatitis	2.72e-05	0.000363	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.7e-05	0.000361	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL5—atopic dermatitis	2.69e-05	0.00036	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.69e-05	0.000359	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.65e-05	0.000355	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.61e-05	0.000349	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CCR5—atopic dermatitis	2.54e-05	0.00034	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.54e-05	0.000339	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARA—atopic dermatitis	2.5e-05	0.000335	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GLB1—atopic dermatitis	2.47e-05	0.000331	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARA—atopic dermatitis	2.41e-05	0.000323	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADSL—atopic dermatitis	2.37e-05	0.000317	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL5—atopic dermatitis	2.34e-05	0.000313	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.34e-05	0.000313	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—atopic dermatitis	2.3e-05	0.000307	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL10—atopic dermatitis	2.29e-05	0.000307	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARA—atopic dermatitis	2.25e-05	0.0003	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—atopic dermatitis	2.2e-05	0.000294	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NGF—atopic dermatitis	2.17e-05	0.00029	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR5—atopic dermatitis	2.11e-05	0.000282	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—atopic dermatitis	2.06e-05	0.000275	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARA—atopic dermatitis	2.04e-05	0.000273	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK8—atopic dermatitis	2.02e-05	0.00027	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL5—atopic dermatitis	1.98e-05	0.000264	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—atopic dermatitis	1.89e-05	0.000253	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NGF—atopic dermatitis	1.83e-05	0.000245	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GLB1—atopic dermatitis	1.82e-05	0.000244	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NFKBIA—atopic dermatitis	1.79e-05	0.000239	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR5—atopic dermatitis	1.78e-05	0.000238	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.76e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADSL—atopic dermatitis	1.75e-05	0.000234	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.72e-05	0.00023	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARA—atopic dermatitis	1.66e-05	0.000221	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.65e-05	0.00022	CbGpPWpGaD
Doxorubicin—TOP2A—Methyltestosterone—Hydrocortisone—atopic dermatitis	1.62e-05	0.00216	CbGdCrCtD
Doxorubicin—NOS3—Disease—CD4—atopic dermatitis	1.6e-05	0.000214	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARA—atopic dermatitis	1.59e-05	0.000212	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—atopic dermatitis	1.55e-05	0.000207	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NFKBIA—atopic dermatitis	1.51e-05	0.000202	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—atopic dermatitis	1.47e-05	0.000197	CbGpPWpGaD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—atopic dermatitis	1.4e-05	0.00186	CbGdCrCtD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.4e-05	0.000187	CbGpPWpGaD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—atopic dermatitis	1.36e-05	0.00182	CbGdCrCtD
Doxorubicin—RALBP1—Signaling Pathways—IL6—atopic dermatitis	1.29e-05	0.000173	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—atopic dermatitis	1.27e-05	0.00017	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.26e-05	0.000169	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARA—atopic dermatitis	1.24e-05	0.000166	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—atopic dermatitis	1.22e-05	0.000163	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARA—atopic dermatitis	1.2e-05	0.000161	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.12e-05	0.00015	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK8—atopic dermatitis	1.12e-05	0.00015	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—atopic dermatitis	1.11e-05	0.000149	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000146	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.08e-05	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—atopic dermatitis	1.08e-05	0.000144	CbGpPWpGaD
Doxorubicin—TOP2A—Norethindrone—Hydrocortisone—atopic dermatitis	1.06e-05	0.00141	CbGdCrCtD
Doxorubicin—NOS3—Signaling Pathways—IL2—atopic dermatitis	1.03e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—atopic dermatitis	1.02e-05	0.000137	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—atopic dermatitis	9.72e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—atopic dermatitis	9.46e-06	0.000127	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—atopic dermatitis	8.63e-06	0.000115	CbGpPWpGaD
Doxorubicin—TOP2A—Levonorgestrel—Hydrocortisone—atopic dermatitis	8.41e-06	0.00112	CbGdCrCtD
Doxorubicin—CYP2B6—Metabolism—PPARA—atopic dermatitis	8.02e-06	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—atopic dermatitis	7.15e-06	9.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—atopic dermatitis	6.04e-06	8.09e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARA—atopic dermatitis	5.92e-06	7.91e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARA—atopic dermatitis	5.57e-06	7.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—atopic dermatitis	5.26e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.64e-06	4.88e-05	CbGpPWpGaD
